FDA proposes ending use of popular decongestant present in cold medicines
The US Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups.
FDA moves to pull popular decongestant from shelves amid effectiveness concerns
The US Food and Drug Administration announced a proposal to remove oral phenylephrine – a common ingredient in many popular ...
U.S. FDA proposes ending use of popular decongestant present in cold medicines
The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an ...
ConsumerAffairs14h
FDA proposes removing popular decongestant found in cold meds
The Food and Drug Administration (FDA) is proposing to officially remove a popular ingredient in many cold and allergy ...
FDA proposes ending use of decongestant found in many cold, allergy medicines
An extensive review determined that the ingredient, oral phenylephrine, doesn’t actually relieve nasal congestion.
FDA wants to remove popular decongestants from stores permanently that contain this ingredient
ATLANTA — The Food and Drug Administration says it wants to remove some of the most popular over-the-counter decongestants ...
FDA says commonly used decongestant 'not effective,' proposes removal
The U.S. Food and Drug Administration has determined commonly used oral phenylephrine is "not effective" and has proposed its ...
Urgent warning to millions who use popular over-the-counter cold and flu remedy that could ‘worsen breathing’
AS COLD and flu season hits, a GP has issued a warning over a common remedy that could cause symptoms to “come back with a ...
MedPage Today on MSN1d
FDA Plans to Ban Popular Cold Med
"Based on our review of available data, and consistent with the advice of the advisory committee, we are taking this next step in the process to propose removing oral phenylephrine because it is not ...
Yahoo16h
The FDA wants to ban a common ingredient in over-the-counter cold and allergy medications
The U.S. Food and Drug Administration (FDA) announced today that it is proposing a new rule to stop the use of an ingredient ...
Zealand Pharma to start Phase 2b trial for obesity drug candidate in Q4
Danish biotechnology company Zealand Pharma said on Thursday it expected to initiate a phase 2b trial with its obesity ...